Daniel J Levitt's Net Worth

$221 Thousand

Estimate Recalculated Apr 5, 2024 03:35PM EST

Who is Daniel J Levitt?

Daniel J Levitt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CYTRX CORP, DYNAVAX TECHNOLOGIES CORP, Sorrento Therapeutics, Inc., and AQUINOX PHARMACEUTICALS, INC.

SEC CIK

Daniel J Levitt's CIK is 0001278711

Past Insider Trading and Trends

2014 was Daniel J Levitt's most active year for acquiring shares with 6 total transactions. Daniel J Levitt's most active month to acquire stocks was the month of November. 2018 was Daniel J Levitt's most active year for disposing of shares, totalling 2 transactions. Daniel J Levitt's most active month to dispose stocks was the month of April. 2005 saw Daniel J Levitt paying a total of $374,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2018 Daniel J Levitt cashed out on 7,812 shares for a total of $49,489.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CYTRX CORP (LADX) Snapshot price: $1.5

EVP and Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Dec 15
Form 4/A
+163.84%
100K
—
—
161.04K
Jan 1
Form 4/A
+172.46%
100K
—
—
157.98K
Jan 1
Form 4/A
+173.29%
100K
—
—
157.71K
Jan 1
Form 4
+87.50%
100K
—
—
214.29K
Jan 1
Form 4
—
0
—
—
0
Dec 10
Form 4/A
+699.99%
100K
—
—
114.29K
Dec 31
Form 4
+100.00%
100K
—
—
200K
Dec 31
Form 4
∞
100K
$0.29
$28,750.00
100K
Feb 22
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.945

Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Jan 20
Form 3
—
0
—
—
0
No matching records found

Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.0375

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

AQUINOX PHARMACEUTICALS, INC (NLTX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$11.62
-$8,241.66
0
May 14
Form 4
—
0
—
—
0
May 7
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
—
—
0
Mar 6
Form 3
—
0
—
—
0
No matching records found